Segment disclosures

Company overview

Cencora, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

72 dimension combinations 574 retained observations 62 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Alliance Healthcare · International Healthcare Solutions

Consolidation Items · Product Or Service · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cor:AllianceHealthcareMember;us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-316516466000 USD20260506Open filing evidence
2025-10-01 – 2026-03-3113047163000 USD20260506Open filing evidence
2025-10-01 – 2025-12-316530697000 USD20260204Open filing evidence
2025-01-01 – 2025-03-315771991000 USD20260506Open filing evidence
2024-10-01 – 2025-03-3111771191000 USD20260506Open filing evidence
2024-10-01 – 2024-12-315999200000 USD20260204Open filing evidence

Operating Segments · Other Healthcare Solutions · International Healthcare Solutions

Consolidation Items · Product Or Service · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cor:OtherHealthcareSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-311049283000 USD20260506Open filing evidence
2025-10-01 – 2026-03-312142559000 USD20260506Open filing evidence
2025-10-01 – 2025-12-311093276000 USD20260204Open filing evidence
2025-01-01 – 2025-03-31924788000 USD20260506Open filing evidence
2024-10-01 – 2025-03-311884483000 USD20260506Open filing evidence
2024-10-01 – 2024-12-31959695000 USD20260204Open filing evidence

Operating Segments · Global Commercialization Services

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:GlobalCommercializationServicesMember
PeriodValueUnitFiledEvidence
2018-10-01 – 2019-09-302893109000 USD2019-11-20 · 03:11:19.000ZOpen filing evidence
2017-10-01 – 2018-09-302542971000 USD2019-11-20 · 03:11:19.000ZOpen filing evidence
2016-10-01 – 2017-09-302111558000 USD2019-11-20 · 03:11:19.000ZOpen filing evidence

Operating Segments · International Healthcare Solutions

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:InternationalHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2022-10-01 – 2022-12-316611278000 USD20230201Open filing evidence
2022-04-01 – 2022-06-306676726000 USD20220803Open filing evidence
2021-10-01 – 2022-06-3020104199000 USD20220803Open filing evidence
2021-10-01 – 2021-12-316649782000 USD20230201Open filing evidence
2021-04-01 – 2021-06-303030769000 USD20220803Open filing evidence
2020-10-01 – 2021-06-304964112000 USD20220803Open filing evidence
2020-10-01 – 2020-12-31944311000 USD20220202Open filing evidence

Operating Segments · International Healthcare Solutions · Alliance Healthcare

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:InternationalHealthcareSolutionsMember;us-gaap:SubsegmentsAxis=abc:AllianceHealthcareMember
PeriodValueUnitFiledEvidence
2021-10-01 – 2021-12-315556671000 USD20220202Open filing evidence
2020-10-01 – 2020-12-310 USD20220202Open filing evidence

Operating Segments · International Healthcare Solutions · Other Healthcare Solutions

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:InternationalHealthcareSolutionsMember;us-gaap:SubsegmentsAxis=abc:OtherHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2021-10-01 – 2021-12-311093111000 USD20220202Open filing evidence
2020-10-01 – 2020-12-31944311000 USD20220202Open filing evidence

Operating Segments · MWI Animal Health

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:MWIAnimalHealthMember
PeriodValueUnitFiledEvidence
2018-10-01 – 2019-09-303975232000 USD2019-11-20 · 03:11:19.000ZOpen filing evidence
2017-10-01 – 2018-09-303789759000 USD2019-11-20 · 03:11:19.000ZOpen filing evidence
2016-10-01 – 2017-09-303636305000 USD2019-11-20 · 03:11:19.000ZOpen filing evidence

Operating Segments · Pharmaceutical Distribution

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:PharmaceuticalDistributionMember
PeriodValueUnitFiledEvidence
2019-10-01 – 2020-09-30182467189000 USD20201119Open filing evidence
2020-01-01 – 2020-03-3145562670000 USD20200507Open filing evidence
2019-10-01 – 2020-03-3191599498000 USD20200507Open filing evidence
2019-10-01 – 2019-12-3146036828000 USD20200130Open filing evidence
2018-10-01 – 2019-09-30172813537000 USD20201119Open filing evidence
2019-04-01 – 2019-06-3043527552000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2018-10-01 – 2019-06-30128948097000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2019-01-01 – 2019-03-3141676164000 USD20200507Open filing evidence
2018-10-01 – 2019-03-3185420545000 USD20200507Open filing evidence
2018-10-01 – 2018-12-3143744381000 USD20200130Open filing evidence
2017-10-01 – 2018-09-30161699343000 USD20201119Open filing evidence
2018-04-01 – 2018-06-3041581866000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2017-10-01 – 2018-06-30119972917000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2018-01-01 – 2018-03-3139453353000 USD20190502Open filing evidence
2017-10-01 – 2018-03-3178391051000 USD20190502Open filing evidence
2017-10-01 – 2017-12-3138937698000 USD20190131Open filing evidence
2016-10-01 – 2017-09-30147453495000 USD2019-11-20 · 03:11:19.000ZOpen filing evidence
2017-04-01 – 2017-06-3037255195000 USD20180802Open filing evidence
2016-10-01 – 2017-06-30109798844000 USD20180802Open filing evidence
2015-10-01 – 2016-09-30141701997000 USD20181120Open filing evidence

Operating Segments · US Healthcare Solutions

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:USHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-3059900199000 USD20230802Open filing evidence
2022-10-01 – 2023-06-30172830234000 USD20230802Open filing evidence
2023-01-01 – 2023-03-3156693456000 USD20230502Open filing evidence
2022-10-01 – 2023-03-31112930035000 USD20230502Open filing evidence
2022-04-01 – 2022-06-3053389345000 USD20230802Open filing evidence
2021-10-01 – 2022-06-30157311755000 USD20230802Open filing evidence
2022-01-01 – 2022-03-3150942763000 USD20230502Open filing evidence
2021-10-01 – 2022-03-31103922410000 USD20230502Open filing evidence
2021-10-01 – 2021-12-3152979647000 USD20220202Open filing evidence
2021-01-01 – 2021-03-3148165587000 USD20220504Open filing evidence
2020-10-01 – 2021-03-3199738168000 USD20220504Open filing evidence
2020-10-01 – 2020-12-3151572581000 USD20220202Open filing evidence

Operating Segments · US Healthcare Solutions · Animal Health

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:USHealthcareSolutionsMember;us-gaap:SubsegmentsAxis=abc:AnimalHealthMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-301316814000 USD20230802Open filing evidence
2022-10-01 – 2023-06-303716272000 USD20230802Open filing evidence
2022-04-01 – 2022-06-301221215000 USD20230802Open filing evidence
2021-10-01 – 2022-06-303590715000 USD20230802Open filing evidence
2022-01-01 – 2022-03-311171982000 USD20220504Open filing evidence
2021-10-01 – 2022-03-312369500000 USD20220504Open filing evidence
2021-10-01 – 2021-12-311197518000 USD20220202Open filing evidence
2021-01-01 – 2021-03-311128405000 USD20220504Open filing evidence
2020-10-01 – 2021-03-312248963000 USD20220504Open filing evidence
2020-10-01 – 2020-12-311120558000 USD20220202Open filing evidence

Operating Segments · US Healthcare Solutions · Human Health

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:USHealthcareSolutionsMember;us-gaap:SubsegmentsAxis=abc:HumanHealthMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-3058583385000 USD20230802Open filing evidence
2022-10-01 – 2023-06-30169113962000 USD20230802Open filing evidence
2022-04-01 – 2022-06-3052168130000 USD20230802Open filing evidence
2021-10-01 – 2022-06-30153721040000 USD20230802Open filing evidence
2022-01-01 – 2022-03-3149770781000 USD20220504Open filing evidence
2021-10-01 – 2022-03-31101552910000 USD20220504Open filing evidence
2021-01-01 – 2021-03-3147037182000 USD20220504Open filing evidence
2020-10-01 – 2021-03-3197489205000 USD20220504Open filing evidence

Operating Segments · International Healthcare Solutions

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-307680456000 USD20260805Open filing evidence
2025-10-01 – 2026-06-3022870178000 USD20260805Open filing evidence
2026-01-01 – 2026-03-317565749000 USD20260506Open filing evidence
2025-10-01 – 2026-03-3115189722000 USD20260506Open filing evidence
2025-10-01 – 2025-12-317623973000 USD20260204Open filing evidence
2024-10-01 – 2025-09-3030366323000 USD20251125Open filing evidence
2025-04-01 – 2025-06-307253396000 RestatedUSD20260805Open filing evidence
2024-10-01 – 2025-06-3020909070000 RestatedUSD20260805Open filing evidence
2025-01-01 – 2025-03-316696779000 RestatedUSD20260506Open filing evidence
2024-10-01 – 2025-03-3113655674000 RestatedUSD20260506Open filing evidence
2024-10-01 – 2024-12-316958895000 RestatedUSD20260204Open filing evidence
2023-10-01 – 2024-09-3028627542000 USD20251125Open filing evidence
2024-04-01 – 2024-06-307051876000 USD20250806Open filing evidence
2023-10-01 – 2024-06-3021245488000 USD20250806Open filing evidence
2024-01-01 – 2024-03-317123385000 USD20250507Open filing evidence
2023-10-01 – 2024-03-3114193612000 USD20250507Open filing evidence
2023-10-01 – 2023-12-317070227000 USD20250205Open filing evidence
2022-10-01 – 2023-09-3027418679000 USD20251125Open filing evidence
2023-04-01 – 2023-06-307047777000 USD20240731Open filing evidence
2022-10-01 – 2023-06-3020423990000 USD20240731Open filing evidence
2023-01-01 – 2023-03-316764935000 USD20240501Open filing evidence
2022-10-01 – 2023-03-3113376213000 USD20240501Open filing evidence
2022-10-01 – 2022-12-316611278000 USD20240131Open filing evidence
2021-10-01 – 2022-09-3026491673000 USD20241126Open filing evidence

Operating Segments · International Healthcare Solutions · Alliance Healthcare

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember;us-gaap:SubsegmentsAxis=cor:AllianceHealthcareMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-315771990000 USD20250507Open filing evidence
2024-10-01 – 2025-03-3111771190000 USD20250507Open filing evidence
2024-10-01 – 2024-12-315999200000 USD20250205Open filing evidence
2023-10-01 – 2024-09-3023061721000 USD20241126Open filing evidence
2024-01-01 – 2024-03-315754980000 USD20250507Open filing evidence
2023-10-01 – 2024-03-3111480544000 USD20250507Open filing evidence
2023-10-01 – 2023-12-315725564000 USD20250205Open filing evidence
2022-10-01 – 2023-09-3022349278000 USD20241126Open filing evidence
2021-10-01 – 2022-09-3021890402000 USD20241126Open filing evidence

Operating Segments · International Healthcare Solutions · Other Healthcare Solutions

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember;us-gaap:SubsegmentsAxis=cor:OtherHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-311401566000 USD20250507Open filing evidence
2024-10-01 – 2025-03-312859707000 USD20250507Open filing evidence
2024-10-01 – 2024-12-311458141000 USD20250205Open filing evidence
2023-10-01 – 2024-09-305565821000 USD20241126Open filing evidence
2024-01-01 – 2024-03-311368405000 USD20250507Open filing evidence
2023-10-01 – 2024-03-312713068000 USD20250507Open filing evidence
2023-10-01 – 2023-12-311344663000 USD20250205Open filing evidence
2022-10-01 – 2023-09-305069401000 USD20241126Open filing evidence
2021-10-01 – 2022-09-304601271000 USD20241126Open filing evidence

Operating Segments · US Healthcare Solutions

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cor:USHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3074860763000 USD20260805Open filing evidence
2025-10-01 – 2026-06-30219837666000 USD20260805Open filing evidence
2026-01-01 – 2026-03-3168765078000 USD20260506Open filing evidence
2025-10-01 – 2026-03-31144976903000 USD20260506Open filing evidence
2025-10-01 – 2025-12-3176211825000 USD20260204Open filing evidence
2024-10-01 – 2025-09-30290982023000 USD20251125Open filing evidence
2025-04-01 – 2025-06-3071342873000 RestatedUSD20260805Open filing evidence
2024-10-01 – 2025-06-30210717432000 RestatedUSD20260805Open filing evidence
2025-01-01 – 2025-03-3166819265000 RestatedUSD20260506Open filing evidence
2024-10-01 – 2025-03-31139374559000 RestatedUSD20260506Open filing evidence
2024-10-01 – 2024-12-3172555294000 RestatedUSD20260204Open filing evidence
2023-10-01 – 2024-09-30265339427000 USD20251125Open filing evidence
2024-04-01 – 2024-06-3067191598000 USD20250806Open filing evidence
2023-10-01 – 2024-06-30193668297000 USD20250806Open filing evidence
2024-01-01 – 2024-03-3161292897000 USD20250507Open filing evidence
2023-10-01 – 2024-03-31126476699000 USD20250507Open filing evidence
2023-10-01 – 2023-12-3165183802000 USD20250205Open filing evidence
2022-10-01 – 2023-09-30234759218000 USD20251125Open filing evidence
2023-04-01 – 2023-06-3059900199000 USD20240731Open filing evidence
2022-10-01 – 2023-06-30172830234000 USD20240731Open filing evidence
2023-01-01 – 2023-03-3156693456000 USD20240501Open filing evidence
2022-10-01 – 2023-03-31112930035000 USD20240501Open filing evidence
2021-10-01 – 2022-09-30212100202000 USD20241126Open filing evidence
2020-10-01 – 2021-09-30202461545000 USD20231121Open filing evidence

Operating Segments · US Healthcare Solutions · Animal Health

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cor:USHealthcareSolutionsMember;us-gaap:SubsegmentsAxis=cor:AnimalHealthMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-311363032000 USD20250507Open filing evidence
2024-10-01 – 2025-03-312743017000 USD20250507Open filing evidence
2024-10-01 – 2024-12-311379985000 USD20250205Open filing evidence
2023-10-01 – 2024-09-305365518000 USD20241126Open filing evidence
2024-01-01 – 2024-03-311308538000 USD20250507Open filing evidence
2023-10-01 – 2024-03-312594175000 USD20250507Open filing evidence
2023-10-01 – 2023-12-311285637000 USD20250205Open filing evidence
2022-10-01 – 2023-09-305042549000 USD20241126Open filing evidence
2023-01-01 – 2023-03-311239492000 USD20240501Open filing evidence
2022-10-01 – 2023-03-312399458000 USD20240501Open filing evidence
2021-10-01 – 2022-09-304815758000 USD20241126Open filing evidence

Operating Segments · US Healthcare Solutions · Human Health

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cor:USHealthcareSolutionsMember;us-gaap:SubsegmentsAxis=cor:HumanHealthMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-3166920799000 USD20250507Open filing evidence
2024-10-01 – 2025-03-31139573942000 USD20250507Open filing evidence
2024-10-01 – 2024-12-3172653143000 USD20250205Open filing evidence
2023-10-01 – 2024-09-30259973909000 USD20241126Open filing evidence
2024-01-01 – 2024-03-3159984359000 USD20250507Open filing evidence
2023-10-01 – 2024-03-31123882524000 USD20250507Open filing evidence
2023-10-01 – 2023-12-3163898165000 USD20250205Open filing evidence
2022-10-01 – 2023-09-30229716669000 USD20241126Open filing evidence
2021-10-01 – 2022-09-30207284444000 USD20241126Open filing evidence

Operating Segments · All Other Segments

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2020-10-01 – 2021-09-3015974799000 USD20211123Open filing evidence
2019-10-01 – 2020-09-307525102000 USD20211123Open filing evidence
2020-01-01 – 2020-03-311876593000 USD20200507Open filing evidence
2019-10-01 – 2020-03-313723577000 USD20200507Open filing evidence
2019-10-01 – 2019-12-311846984000 USD20200130Open filing evidence
2018-10-01 – 2019-09-306868341000 USD20211123Open filing evidence
2019-04-01 – 2019-06-301734538000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2018-10-01 – 2019-06-305070905000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2019-01-01 – 2019-03-311665429000 USD20200507Open filing evidence
2018-10-01 – 2019-03-313336367000 USD20200507Open filing evidence
2018-10-01 – 2018-12-311670938000 USD20200130Open filing evidence
2017-10-01 – 2018-09-306332730000 USD20201119Open filing evidence
2018-04-01 – 2018-06-301597223000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2017-10-01 – 2018-06-304736552000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2018-01-01 – 2018-03-311594378000 USD20190502Open filing evidence
2017-10-01 – 2018-03-313139329000 USD20190502Open filing evidence
2017-10-01 – 2017-12-311544951000 USD20190131Open filing evidence
2016-10-01 – 2017-09-305747863000 USD2019-11-20 · 03:11:19.000ZOpen filing evidence
2017-04-01 – 2017-06-301467536000 USD20180802Open filing evidence
2016-10-01 – 2017-06-304267876000 USD20180802Open filing evidence
2015-10-01 – 2016-09-305207095000 USD20181120Open filing evidence

Operating Segments · All Other Segments · Global Commercialization Services

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;us-gaap:SubsegmentsAxis=abc:GlobalCommercializationServicesMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-31833577000 USD20200507Open filing evidence
2019-10-01 – 2020-03-311652243000 USD20200507Open filing evidence
2019-10-01 – 2019-12-31818666000 USD20200130Open filing evidence
2019-04-01 – 2019-06-30712602000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2018-10-01 – 2019-06-302147092000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2019-01-01 – 2019-03-31718136000 USD20200507Open filing evidence
2018-10-01 – 2019-03-311434490000 USD20200507Open filing evidence
2018-10-01 – 2018-12-31716354000 USD20200130Open filing evidence
2018-04-01 – 2018-06-30651881000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2017-10-01 – 2018-06-301899635000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2018-01-01 – 2018-03-31661375000 USD20190502Open filing evidence
2017-10-01 – 2018-03-311247754000 USD20190502Open filing evidence
2017-10-01 – 2017-12-31586379000 USD20190131Open filing evidence

Operating Segments · All Other Segments · MWI Animal Health

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;us-gaap:SubsegmentsAxis=abc:MWIAnimalHealthMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-311043016000 USD20200507Open filing evidence
2019-10-01 – 2020-03-312071334000 USD20200507Open filing evidence
2019-10-01 – 2019-12-311028318000 USD20200130Open filing evidence
2019-04-01 – 2019-06-301021936000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2018-10-01 – 2019-06-302923813000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2019-01-01 – 2019-03-31947293000 USD20200507Open filing evidence
2018-10-01 – 2019-03-311901877000 USD20200507Open filing evidence
2018-10-01 – 2018-12-31954584000 USD20200130Open filing evidence
2018-04-01 – 2018-06-30945342000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2017-10-01 – 2018-06-302836917000 USD2019-08-01 · 22:24:51.000ZOpen filing evidence
2018-01-01 – 2018-03-31933003000 USD20190502Open filing evidence
2017-10-01 – 2018-03-311891575000 USD20190502Open filing evidence
2017-10-01 – 2017-12-31958572000 USD20190131Open filing evidence

Operating Segments · Alliance Healthcare · International Healthcare Solutions

Consolidation Items · Subsegments · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=cor:AllianceHealthcareMember;us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2024-10-01 – 2025-09-3024394833000 USD20251125Open filing evidence
2025-04-01 – 2025-06-306229964000 USD20250806Open filing evidence
2024-10-01 – 2025-06-3018001154000 USD20250806Open filing evidence
2023-10-01 – 2024-09-3023061721000 USD20251125Open filing evidence
2024-04-01 – 2024-06-305641912000 USD20250806Open filing evidence
2023-10-01 – 2024-06-3017122456000 USD20250806Open filing evidence
2024-01-01 – 2024-03-315754980000 USD20240501Open filing evidence
2023-10-01 – 2024-03-3111480544000 USD20240501Open filing evidence
2022-10-01 – 2023-09-3022349278000 USD20251125Open filing evidence
2023-04-01 – 2023-06-305698635000 USD20240731Open filing evidence
2022-10-01 – 2023-06-3016720262000 USD20240731Open filing evidence
2023-01-01 – 2023-03-315560936000 USD20240501Open filing evidence
2022-10-01 – 2023-03-3111021627000 USD20240501Open filing evidence

Operating Segments · Animal Health · US Healthcare Solutions

Consolidation Items · Subsegments · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=cor:AnimalHealthMember;us-gaap:StatementBusinessSegmentsAxis=cor:USHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2024-10-01 – 2025-09-305694517000 USD20251125Open filing evidence
2025-04-01 – 2025-06-301471692000 USD20250806Open filing evidence
2024-10-01 – 2025-06-304214709000 USD20250806Open filing evidence
2023-10-01 – 2024-09-305365518000 USD20251125Open filing evidence
2024-04-01 – 2024-06-301369735000 USD20250806Open filing evidence
2023-10-01 – 2024-06-303963910000 USD20250806Open filing evidence
2022-10-01 – 2023-09-305042549000 USD20251125Open filing evidence
2023-04-01 – 2023-06-301316814000 USD20240731Open filing evidence
2022-10-01 – 2023-06-303716272000 USD20240731Open filing evidence

Operating Segments · Human Health · US Healthcare Solutions

Consolidation Items · Subsegments · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=cor:HumanHealthMember;us-gaap:StatementBusinessSegmentsAxis=cor:USHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2024-10-01 – 2025-09-30285287506000 USD20251125Open filing evidence
2025-04-01 – 2025-06-3071404871000 USD20250806Open filing evidence
2024-10-01 – 2025-06-30210978813000 USD20250806Open filing evidence
2023-10-01 – 2024-09-30259973909000 USD20251125Open filing evidence
2024-04-01 – 2024-06-3065821863000 USD20250806Open filing evidence
2023-10-01 – 2024-06-30189704387000 USD20250806Open filing evidence
2022-10-01 – 2023-09-30229716669000 USD20251125Open filing evidence
2023-04-01 – 2023-06-3058583385000 USD20240731Open filing evidence
2022-10-01 – 2023-06-30169113962000 USD20240731Open filing evidence
2021-10-01 – 2022-09-30207284444000 USD20231121Open filing evidence
2020-10-01 – 2021-09-30197777128000 USD20231121Open filing evidence

Operating Segments · Other Healthcare Solutions · International Healthcare Solutions

Consolidation Items · Subsegments · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=cor:OtherHealthcareSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2024-10-01 – 2025-09-305971490000 USD20251125Open filing evidence
2025-04-01 – 2025-06-301560474000 USD20250806Open filing evidence
2024-10-01 – 2025-06-304420181000 USD20250806Open filing evidence
2023-10-01 – 2024-09-305565821000 USD20251125Open filing evidence
2024-04-01 – 2024-06-301409964000 USD20250806Open filing evidence
2023-10-01 – 2024-06-304123032000 USD20250806Open filing evidence
2024-01-01 – 2024-03-311368405000 USD20240501Open filing evidence
2023-10-01 – 2024-03-312713068000 USD20240501Open filing evidence
2022-10-01 – 2023-09-305069401000 USD20251125Open filing evidence
2023-04-01 – 2023-06-301349142000 USD20240731Open filing evidence
2022-10-01 – 2023-06-303703728000 USD20240731Open filing evidence
2023-01-01 – 2023-03-311203999000 USD20240501Open filing evidence
2022-10-01 – 2023-03-312354586000 USD20240501Open filing evidence

Alliance Healthcare · International Healthcare Solutions · Operating Segments

Product Or Service · Statement Business Segments · Consolidation Items

Source dimensions srt:ProductOrServiceAxis=cor:AllianceHealthcareMember;us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-306601430000 USD20260805Open filing evidence
2025-10-01 – 2026-06-3019648593000 USD20260805Open filing evidence
2025-04-01 – 2025-06-306229963000 USD20260805Open filing evidence
2024-10-01 – 2025-06-3018001154000 USD20260805Open filing evidence

Other Healthcare Solutions · International Healthcare Solutions · Operating Segments

Product Or Service · Statement Business Segments · Consolidation Items

Source dimensions srt:ProductOrServiceAxis=cor:OtherHealthcareSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301079026000 USD20260805Open filing evidence
2025-10-01 – 2026-06-303221585000 USD20260805Open filing evidence
2025-04-01 – 2025-06-301023433000 USD20260805Open filing evidence
2024-10-01 – 2025-06-302907916000 USD20260805Open filing evidence

Operating Segments · Pharmaceutical Distribution

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:PharmaceuticalDistributionMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-3139453353000 USD20180502Open filing evidence
2017-10-01 – 2018-03-3178391051000 USD20180502Open filing evidence
2017-10-01 – 2017-12-3138937698000 USD20180206Open filing evidence
2016-10-01 – 2017-09-30147453495000 USD20171121Open filing evidence
2017-04-01 – 2017-06-3037032709000 USD20170803Open filing evidence
2016-10-01 – 2017-06-30109127631000 USD20170803Open filing evidence
2017-01-01 – 2017-03-3135745360000 RestatedUSD20180502Open filing evidence
2016-10-01 – 2017-03-3172543649000 RestatedUSD20180502Open filing evidence
2016-10-01 – 2016-12-3136798289000 RestatedUSD20180206Open filing evidence
2015-10-01 – 2016-09-30141701997000 RestatedUSD20171121Open filing evidence
2016-04-01 – 2016-06-3035373725000 USD20170803Open filing evidence
2015-10-01 – 2016-06-30104734137000 USD20170803Open filing evidence
2016-01-01 – 2016-03-3134165733000 USD20170504Open filing evidence
2015-10-01 – 2016-03-3169360412000 USD20170504Open filing evidence
2015-10-01 – 2015-12-3135194679000 USD20170131Open filing evidence
2014-10-01 – 2015-09-30132383820000 RestatedUSD20171121Open filing evidence
2015-04-01 – 2015-06-3032758828000 USD20160802Open filing evidence
2014-10-01 – 2015-06-3097504075000 USD20160802Open filing evidence
2015-01-01 – 2015-03-3131762523000 USD20160505Open filing evidence
2014-10-01 – 2015-03-3164745247000 USD20160505Open filing evidence
2014-10-01 – 2014-12-3132982724000 USD20160204Open filing evidence
2013-10-01 – 2014-09-30117383967000 USD20161122Open filing evidence
2014-04-01 – 2014-06-3029812837000 USD20150806Open filing evidence
2013-10-01 – 2014-06-3086367923000 USD20150806Open filing evidence
2014-01-01 – 2014-03-3127932495000 USD20150508Open filing evidence
2013-10-01 – 2014-03-3156555086000 USD20150508Open filing evidence
2013-10-01 – 2013-12-3128622591000 USD20150206Open filing evidence
2013-04-01 – 2013-06-3021407853000 USD20140807Open filing evidence
2012-10-01 – 2013-06-3062061060000 USD20140807Open filing evidence
2013-01-01 – 2013-03-3120054159000 USD20140507Open filing evidence
2012-10-01 – 2013-03-3140653207000 USD20140507Open filing evidence

Operating Segments · All Other Segments

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-311594378000 USD20180502Open filing evidence
2017-10-01 – 2018-03-313139329000 USD20180502Open filing evidence
2017-10-01 – 2017-12-311544951000 USD20180206Open filing evidence
2016-10-01 – 2017-09-305747863000 USD20171121Open filing evidence
2017-04-01 – 2017-06-301743954000 USD20170803Open filing evidence
2016-10-01 – 2017-06-305103745000 USD20170803Open filing evidence
2017-01-01 – 2017-03-311415850000 RestatedUSD20180502Open filing evidence
2016-10-01 – 2017-03-312800340000 RestatedUSD20180502Open filing evidence
2016-10-01 – 2016-12-311384490000 RestatedUSD20180206Open filing evidence
2015-10-01 – 2016-09-305207095000 RestatedUSD20171121Open filing evidence
2016-04-01 – 2016-06-301576368000 USD20170803Open filing evidence
2015-10-01 – 2016-06-304753988000 USD20170803Open filing evidence
2016-01-01 – 2016-03-311599805000 USD20170504Open filing evidence
2015-10-01 – 2016-03-313177620000 USD20170504Open filing evidence
2015-10-01 – 2015-12-311577815000 USD20170131Open filing evidence
2014-10-01 – 2015-09-303586879000 RestatedUSD20171121Open filing evidence
2015-04-01 – 2015-06-301532907000 USD20160802Open filing evidence
2014-10-01 – 2015-06-303214977000 USD20160802Open filing evidence
2015-01-01 – 2015-03-31986069000 USD20160505Open filing evidence
2014-10-01 – 2015-03-311682070000 USD20160505Open filing evidence
2014-10-01 – 2014-12-31696001000 USD20160204Open filing evidence
2013-10-01 – 2014-09-302449149000 USD20161122Open filing evidence
2014-04-01 – 2014-06-30620275000 USD20150806Open filing evidence
2013-10-01 – 2014-06-301796910000 USD20150806Open filing evidence
2014-01-01 – 2014-03-31572503000 USD20150508Open filing evidence
2013-10-01 – 2014-03-311176635000 USD20150508Open filing evidence
2013-10-01 – 2013-12-31604132000 USD20150206Open filing evidence
2013-04-01 – 2013-06-30549400000 USD20140807Open filing evidence
2012-10-01 – 2013-06-301569392000 USD20140807Open filing evidence
2013-01-01 – 2013-03-31514942000 USD20140507Open filing evidence
2012-10-01 – 2013-03-311019992000 USD20140507Open filing evidence

Global Commercialization Services · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:GlobalCommercializationServicesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2019-10-01 – 2020-09-303308640000 USD20201119Open filing evidence
2018-10-01 – 2019-09-302893109000 USD20201119Open filing evidence
2017-10-01 – 2018-09-302542971000 USD20201119Open filing evidence

International Healthcare Solutions · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:InternationalHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-307047777000 USD20230802Open filing evidence
2022-10-01 – 2023-06-3020423990000 USD20230802Open filing evidence
2023-01-01 – 2023-03-316764935000 USD20230502Open filing evidence
2022-10-01 – 2023-03-3113376213000 USD20230502Open filing evidence
2021-10-01 – 2022-09-3026491673000 USD20221122Open filing evidence
2022-04-01 – 2022-06-306676726000 USD20230802Open filing evidence
2021-10-01 – 2022-06-3020104199000 USD20230802Open filing evidence
2022-01-01 – 2022-03-316777691000 USD20230502Open filing evidence
2021-10-01 – 2022-03-3113427473000 USD20230502Open filing evidence
2020-10-01 – 2021-09-3011529629000 USD20221122Open filing evidence
2021-01-01 – 2021-03-31989032000 USD20220504Open filing evidence
2020-10-01 – 2021-03-311933343000 USD20220504Open filing evidence
2019-10-01 – 2020-09-303508106000 USD20221122Open filing evidence

International Healthcare Solutions · Operating Segments · Alliance Healthcare

Statement Business Segments · Consolidation Items · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:InternationalHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=abc:AllianceHealthcareMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-305698635000 USD20230802Open filing evidence
2022-10-01 – 2023-06-3016720262000 USD20230802Open filing evidence
2022-04-01 – 2022-06-305492656000 USD20230802Open filing evidence
2021-10-01 – 2022-06-3016658799000 USD20230802Open filing evidence

International Healthcare Solutions · Operating Segments · Other Healthcare Solutions

Statement Business Segments · Consolidation Items · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:InternationalHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=abc:OtherHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-311168219000 USD20220504Open filing evidence
2021-10-01 – 2022-03-312261330000 USD20220504Open filing evidence
2021-01-01 – 2021-03-31989032000 USD20220504Open filing evidence
2020-10-01 – 2021-03-311933343000 USD20220504Open filing evidence

International Healthcare Solutions · Alliance Healthcare · Operating Segments

Statement Business Segments · Subsegments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:InternationalHealthcareSolutionsMember;us-gaap:SubsegmentsAxis=abc:AllianceHealthcareMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-315560936000 USD20230502Open filing evidence
2022-10-01 – 2023-03-3111021627000 USD20230502Open filing evidence
2021-10-01 – 2022-09-3021890402000 USD20221122Open filing evidence
2022-01-01 – 2022-03-315609472000 USD20230502Open filing evidence
2021-10-01 – 2022-03-3111166143000 USD20230502Open filing evidence
2020-10-01 – 2021-09-307373365000 USD20221122Open filing evidence
2021-01-01 – 2021-03-310 USD20220504Open filing evidence
2020-10-01 – 2021-03-310 USD20220504Open filing evidence
2019-10-01 – 2020-09-300 USD20221122Open filing evidence

International Healthcare Solutions · Other Healthcare Solutions · Operating Segments

Statement Business Segments · Subsegments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:InternationalHealthcareSolutionsMember;us-gaap:SubsegmentsAxis=abc:OtherHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-301349142000 USD20230802Open filing evidence
2022-10-01 – 2023-06-303703728000 USD20230802Open filing evidence
2021-10-01 – 2022-09-304601271000 USD20221122Open filing evidence
2022-04-01 – 2022-06-301184070000 USD20230802Open filing evidence
2021-10-01 – 2022-06-303445400000 USD20230802Open filing evidence
2020-10-01 – 2021-09-304156264000 USD20221122Open filing evidence
2019-10-01 – 2020-09-303508106000 USD20221122Open filing evidence

Intersegment Eliminations

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:IntersegmentEliminationsMember
PeriodValueUnitFiledEvidence
2012-10-01 – 2013-09-30-192332000 USD20131126Open filing evidence
2011-10-01 – 2012-09-30-184482000 USD20131126Open filing evidence
2010-10-01 – 2011-09-30-51286000 USD20131126Open filing evidence
2009-10-01 – 2010-09-30-38181000 USD20121127Open filing evidence

MWI Animal Health · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:MWIAnimalHealthMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2019-10-01 – 2020-09-304216462000 USD20201119Open filing evidence
2018-10-01 – 2019-09-303975232000 USD20201119Open filing evidence
2017-10-01 – 2018-09-303789759000 USD20201119Open filing evidence

Other Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:OtherSegmentMember
PeriodValueUnitFiledEvidence
2013-10-01 – 2014-09-302449149000 USD20141125Open filing evidence
2013-10-01 – 2013-12-31604132000 USD20140207Open filing evidence
2012-10-01 – 2013-09-302087968000 RestatedUSD20141125Open filing evidence
2013-04-01 – 2013-06-30466710000 USD20130807Open filing evidence
2012-10-01 – 2013-06-301329984000 USD20130807Open filing evidence
2013-01-01 – 2013-03-31435385000 USD20130509Open filing evidence
2012-10-01 – 2013-03-31863274000 USD20130509Open filing evidence
2012-10-01 – 2012-12-31505050000 RestatedUSD20140207Open filing evidence
2011-10-01 – 2012-09-301575738000 RestatedUSD20141125Open filing evidence
2012-04-01 – 2012-06-30397452000 RestatedUSD20130807Open filing evidence
2011-10-01 – 2012-06-30903178000 RestatedUSD20130807Open filing evidence
2012-01-01 – 2012-03-31296401000 USD20130509Open filing evidence
2011-10-01 – 2012-03-31505726000 USD20130509Open filing evidence
2011-10-01 – 2011-12-31209325000 USD20130208Open filing evidence
2010-10-01 – 2011-09-30302012000 USD20131126Open filing evidence
2011-04-01 – 2011-06-30140100000 USD20120809Open filing evidence
2010-10-01 – 2011-06-30383018000 USD20120809Open filing evidence
2009-10-01 – 2010-09-30261705000 USD20121127Open filing evidence

Pharmaceutical Distribution

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:PharmaceuticalDistributionMember
PeriodValueUnitFiledEvidence
2014-10-01 – 2015-09-30131480550000 USD20151124Open filing evidence
2013-10-01 – 2014-09-30117383967000 USD20151124Open filing evidence
2013-10-01 – 2013-12-3128622591000 USD20140207Open filing evidence
2012-10-01 – 2013-09-3086063531000 RestatedUSD20151124Open filing evidence
2013-04-01 – 2013-06-3021490543000 USD20130807Open filing evidence
2012-10-01 – 2013-06-3062300468000 USD20130807Open filing evidence
2013-01-01 – 2013-03-3120133716000 USD20130509Open filing evidence
2012-10-01 – 2013-03-3140809925000 USD20130509Open filing evidence
2012-10-01 – 2012-12-3120599048000 RestatedUSD20140207Open filing evidence
2011-10-01 – 2012-09-3076689550000 RestatedUSD20141125Open filing evidence
2012-04-01 – 2012-06-3018985491000 RestatedUSD20130807Open filing evidence
2011-10-01 – 2012-06-3058243723000 RestatedUSD20130807Open filing evidence
2012-01-01 – 2012-03-3119454919000 USD20130509Open filing evidence
2011-10-01 – 2012-03-3139258232000 USD20130509Open filing evidence
2011-10-01 – 2011-12-3120134050000 USD20130208Open filing evidence
2010-10-01 – 2011-09-3078444933000 RestatedUSD20131126Open filing evidence
2011-04-01 – 2011-06-3020036062000 USD20120809Open filing evidence
2010-10-01 – 2011-06-3059466510000 USD20120809Open filing evidence
2009-10-01 – 2010-09-3077552936000 USD20121127Open filing evidence

Pharmaceutical Distribution · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:PharmaceuticalDistributionMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2020-10-01 – 2021-09-30198153202000 USD20211123Open filing evidence
2021-04-01 – 2021-06-3049312013000 USD20210804Open filing evidence
2020-10-01 – 2021-06-30146905854000 USD20210804Open filing evidence
2021-01-01 – 2021-03-3147101331000 USD20210505Open filing evidence
2020-10-01 – 2021-03-3197593841000 USD20210505Open filing evidence
2020-10-01 – 2020-12-3150492510000 USD20210204Open filing evidence
2019-10-01 – 2020-09-30182467189000 USD20211123Open filing evidence
2020-04-01 – 2020-06-3043579119000 USD20210804Open filing evidence
2019-10-01 – 2020-06-30135178617000 USD20210804Open filing evidence
2020-01-01 – 2020-03-3145562670000 USD20210505Open filing evidence
2019-10-01 – 2020-03-3191599498000 USD20210505Open filing evidence
2019-10-01 – 2019-12-3146036828000 USD20210204Open filing evidence
2018-10-01 – 2019-09-30172813537000 USD20211123Open filing evidence
2019-04-01 – 2019-06-3043527552000 USD20200805Open filing evidence
2018-10-01 – 2019-06-30128948097000 USD20200805Open filing evidence

US Healthcare Solutions · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:USHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-10-01 – 2022-12-3156236579000 USD20230201Open filing evidence
2022-07-01 – 2022-09-30212100202000 USD20221122Open filing evidence
2021-10-01 – 2022-09-30186387949000 USD20221122Open filing evidence
2022-04-01 – 2022-06-3053389345000 USD20220803Open filing evidence
2021-10-01 – 2022-06-30157311755000 USD20220803Open filing evidence
2021-10-01 – 2021-12-3152979647000 USD20230201Open filing evidence
2021-07-01 – 2021-09-30202461545000 USD20221122Open filing evidence
2021-04-01 – 2021-06-3050375842000 USD20220803Open filing evidence
2020-10-01 – 2021-06-30150114010000 USD20220803Open filing evidence

US Healthcare Solutions · Operating Segments · Animal Health

Statement Business Segments · Consolidation Items · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:USHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=abc:AnimalHealthMember
PeriodValueUnitFiledEvidence
2022-10-01 – 2022-12-311159966000 USD20230201Open filing evidence
2022-04-01 – 2022-06-301221215000 USD20220803Open filing evidence
2021-10-01 – 2022-06-303590715000 USD20220803Open filing evidence
2021-10-01 – 2021-12-311197518000 USD20230201Open filing evidence
2021-04-01 – 2021-06-301193531000 USD20220803Open filing evidence
2020-10-01 – 2021-06-303442494000 USD20220803Open filing evidence

US Healthcare Solutions · Operating Segments · Human Health

Statement Business Segments · Consolidation Items · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:USHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=abc:HumanHealthMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-3052168130000 USD20220803Open filing evidence
2021-10-01 – 2022-06-30153721040000 USD20220803Open filing evidence
2021-04-01 – 2021-06-3049182311000 USD20220803Open filing evidence
2020-10-01 – 2021-06-30146671516000 USD20220803Open filing evidence

US Healthcare Solutions · Human Health · Operating Segments

Statement Business Segments · Subsegments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=abc:USHealthcareSolutionsMember;us-gaap:SubsegmentsAxis=abc:HumanHealthMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-10-01 – 2022-12-3155076613000 USD20230201Open filing evidence
2021-10-01 – 2021-12-3151782129000 USD20230201Open filing evidence

International Healthcare Solutions · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-10-01 – 2023-09-3027418679000 USD20231121Open filing evidence
2021-10-01 – 2022-09-3026491673000 USD20231121Open filing evidence
2020-10-01 – 2021-09-3011529629000 USD20231121Open filing evidence

International Healthcare Solutions · Operating Segments · Alliance Healthcare

Statement Business Segments · Consolidation Items · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=cor:AllianceHealthcareMember
PeriodValueUnitFiledEvidence
2022-10-01 – 2023-09-3022349278000 USD20231121Open filing evidence
2021-10-01 – 2022-09-3021890402000 USD20231121Open filing evidence
2020-10-01 – 2021-09-307373365000 USD20231121Open filing evidence

US Healthcare Solutions · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cor:USHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-10-01 – 2023-12-3165183802000 USD20240131Open filing evidence
2022-10-01 – 2022-12-3156236579000 USD20240131Open filing evidence

US Healthcare Solutions · Human Health · Operating Segments

Statement Business Segments · Subsegments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cor:USHealthcareSolutionsMember;us-gaap:SubsegmentsAxis=cor:HumanHealthMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-10-01 – 2023-12-3163898165000 USD20240131Open filing evidence
2022-10-01 – 2022-12-3155076613000 USD20240131Open filing evidence

All Other Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2014-10-01 – 2015-09-304772178000 USD20151124Open filing evidence
2013-10-01 – 2014-09-302449149000 USD20151124Open filing evidence
2012-10-01 – 2013-09-302087968000 USD20151124Open filing evidence

All Other Segments · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-04-01 – 2021-06-304128266000 USD20210804Open filing evidence
2020-10-01 – 2021-06-308273312000 USD20210804Open filing evidence
2021-01-01 – 2021-03-312092772000 USD20210505Open filing evidence
2020-10-01 – 2021-03-314145046000 USD20210505Open filing evidence
2020-10-01 – 2020-12-312052274000 USD20210204Open filing evidence
2020-04-01 – 2020-06-301810533000 USD20210804Open filing evidence
2019-10-01 – 2020-06-305534110000 USD20210804Open filing evidence
2020-01-01 – 2020-03-311876593000 USD20210505Open filing evidence
2019-10-01 – 2020-03-313723577000 USD20210505Open filing evidence
2019-10-01 – 2019-12-311846984000 USD20210204Open filing evidence
2019-04-01 – 2019-06-301734538000 USD20200805Open filing evidence
2018-10-01 – 2019-06-305070905000 USD20200805Open filing evidence

All Other Segments · Operating Segments · Alliance Healthcare

Statement Business Segments · Consolidation Items · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=abc:AllianceHealthcareMember
PeriodValueUnitFiledEvidence
2021-04-01 – 2021-06-301924858000 USD20210804Open filing evidence
2020-10-01 – 2021-06-301924858000 USD20210804Open filing evidence
2020-04-01 – 2020-06-300 USD20210804Open filing evidence
2019-10-01 – 2020-06-300 USD20210804Open filing evidence

All Other Segments · Operating Segments · MWI Animal Health

Statement Business Segments · Consolidation Items · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=abc:MWIAnimalHealthMember
PeriodValueUnitFiledEvidence
2020-10-01 – 2020-12-311120557000 USD20210204Open filing evidence
2019-10-01 – 2019-12-311028318000 USD20210204Open filing evidence

All Other Segments · Global Commercialization Services · Operating Segments

Statement Business Segments · Subsegments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;us-gaap:SubsegmentsAxis=abc:GlobalCommercializationServicesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-04-01 – 2021-06-301009878000 USD20210804Open filing evidence
2020-10-01 – 2021-06-302905960000 USD20210804Open filing evidence
2021-01-01 – 2021-03-31964365000 USD20210505Open filing evidence
2020-10-01 – 2021-03-311896082000 USD20210505Open filing evidence
2020-04-01 – 2020-06-30801952000 USD20210804Open filing evidence
2019-10-01 – 2020-06-302454195000 USD20210804Open filing evidence
2020-01-01 – 2020-03-31833577000 USD20210505Open filing evidence
2019-10-01 – 2020-03-311652243000 USD20210505Open filing evidence
2019-04-01 – 2019-06-30712602000 USD20200805Open filing evidence
2018-10-01 – 2019-06-302147092000 USD20200805Open filing evidence

All Other Segments · MWI Animal Health · Operating Segments

Statement Business Segments · Subsegments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;us-gaap:SubsegmentsAxis=abc:MWIAnimalHealthMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-03-311128407000 USD20210505Open filing evidence
2020-10-01 – 2021-03-312248964000 USD20210505Open filing evidence
2020-01-01 – 2020-03-311043016000 USD20210505Open filing evidence
2019-10-01 – 2020-03-312071334000 USD20210505Open filing evidence

Intersegment Elimination

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:IntersegmentEliminationMember
PeriodValueUnitFiledEvidence
2013-10-01 – 2014-09-30-263989000 USD20141125Open filing evidence
2013-10-01 – 2013-12-31-50361000 USD20140207Open filing evidence
2012-10-01 – 2013-09-30-192332000 USD20141125Open filing evidence
2013-04-01 – 2013-06-30-50605000 USD20130807Open filing evidence
2012-10-01 – 2013-06-30-140325000 USD20130807Open filing evidence
2013-01-01 – 2013-03-31-45433000 USD20130509Open filing evidence
2012-10-01 – 2013-03-31-89720000 USD20130509Open filing evidence
2012-10-01 – 2012-12-31-44287000 USD20140207Open filing evidence
2011-10-01 – 2012-09-30-184482000 USD20141125Open filing evidence
2012-04-01 – 2012-06-30-56136000 RestatedUSD20130807Open filing evidence
2011-10-01 – 2012-06-30-130538000 RestatedUSD20130807Open filing evidence
2012-01-01 – 2012-03-31-42949000 USD20130509Open filing evidence
2011-10-01 – 2012-03-31-74402000 USD20130509Open filing evidence
2011-10-01 – 2011-12-31-31453000 USD20130208Open filing evidence
2011-04-01 – 2011-06-30-15140000 USD20120809Open filing evidence
2010-10-01 – 2011-06-30-39640000 USD20120809Open filing evidence

Alliance Healthcare · Operating Segments · International Healthcare Solutions

Subsegments · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:SubsegmentsAxis=abc:AllianceHealthcareMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:InternationalHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2022-10-01 – 2022-12-315460691000 USD20230201Open filing evidence
2022-04-01 – 2022-06-305492656000 USD20220803Open filing evidence
2021-10-01 – 2022-06-3016658799000 USD20220803Open filing evidence
2021-10-01 – 2021-12-315556671000 USD20230201Open filing evidence
2021-04-01 – 2021-06-301924858000 USD20220803Open filing evidence
2020-10-01 – 2021-06-301924858000 USD20220803Open filing evidence

Alliance Healthcare · Operating Segments · All Other Segments

Subsegments · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:SubsegmentsAxis=abc:AllianceHealthcareMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2020-10-01 – 2021-09-307373365000 USD20211123Open filing evidence
2019-10-01 – 2020-09-300 USD20211123Open filing evidence
2018-10-01 – 2019-09-300 USD20211123Open filing evidence

Animal Health · Operating Segments · US Healthcare Solutions

Subsegments · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:SubsegmentsAxis=abc:AnimalHealthMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:USHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-311239492000 USD20230502Open filing evidence
2022-10-01 – 2023-03-312399458000 USD20230502Open filing evidence
2022-01-01 – 2022-03-311171982000 USD20230502Open filing evidence
2021-10-01 – 2022-03-312369500000 USD20230502Open filing evidence

Animal Health · US Healthcare Solutions · Operating Segments

Subsegments · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:SubsegmentsAxis=abc:AnimalHealthMember;us-gaap:StatementBusinessSegmentsAxis=abc:USHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-304815758000 USD20221122Open filing evidence
2021-10-01 – 2022-09-304216462000 USD20221122Open filing evidence
2021-07-01 – 2021-09-304684417000 USD20221122Open filing evidence

Global Commercialization Services · Operating Segments · All Other Segments

Subsegments · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:SubsegmentsAxis=abc:GlobalCommercializationServicesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2020-10-01 – 2021-09-303917017000 USD20211123Open filing evidence
2019-10-01 – 2020-09-303308640000 USD20211123Open filing evidence
2018-10-01 – 2019-09-302893109000 USD20211123Open filing evidence

Global Commercialization Services · All Other Segments · Operating Segments

Subsegments · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:SubsegmentsAxis=abc:GlobalCommercializationServicesMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2020-10-01 – 2020-12-31931717000 USD20210204Open filing evidence
2019-10-01 – 2019-12-31818666000 USD20210204Open filing evidence

Human Health · Operating Segments · US Healthcare Solutions

Subsegments · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:SubsegmentsAxis=abc:HumanHealthMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:USHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-3155453964000 USD20230502Open filing evidence
2022-10-01 – 2023-03-31110530577000 USD20230502Open filing evidence
2022-01-01 – 2022-03-3149770781000 USD20230502Open filing evidence
2021-10-01 – 2022-03-31101552910000 USD20230502Open filing evidence
2021-10-01 – 2021-12-3151782129000 USD20220202Open filing evidence
2020-10-01 – 2020-12-3150452023000 USD20220202Open filing evidence

Human Health · US Healthcare Solutions · Operating Segments

Subsegments · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:SubsegmentsAxis=abc:HumanHealthMember;us-gaap:StatementBusinessSegmentsAxis=abc:USHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-30207284444000 USD20221122Open filing evidence
2021-10-01 – 2022-09-30182171487000 USD20221122Open filing evidence
2021-07-01 – 2021-09-30197777128000 USD20221122Open filing evidence

MWI Animal Health · Operating Segments · All Other Segments

Subsegments · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:SubsegmentsAxis=abc:MWIAnimalHealthMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2020-10-01 – 2021-09-304684417000 USD20211123Open filing evidence
2019-10-01 – 2020-09-304216462000 USD20211123Open filing evidence
2018-10-01 – 2019-09-303975232000 USD20211123Open filing evidence

MWI Animal Health · All Other Segments · Operating Segments

Subsegments · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:SubsegmentsAxis=abc:MWIAnimalHealthMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-04-01 – 2021-06-301193530000 USD20210804Open filing evidence
2020-10-01 – 2021-06-303442494000 USD20210804Open filing evidence
2020-04-01 – 2020-06-301008581000 USD20210804Open filing evidence
2019-10-01 – 2020-06-303079915000 USD20210804Open filing evidence
2019-04-01 – 2019-06-301021936000 USD20200805Open filing evidence
2018-10-01 – 2019-06-302923813000 USD20200805Open filing evidence

Other Healthcare Solutions · Operating Segments · International Healthcare Solutions

Subsegments · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:SubsegmentsAxis=abc:OtherHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=abc:InternationalHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2022-10-01 – 2022-12-311150587000 USD20230201Open filing evidence
2022-04-01 – 2022-06-301184070000 USD20220803Open filing evidence
2021-10-01 – 2022-06-303445400000 USD20220803Open filing evidence
2021-10-01 – 2021-12-311093111000 USD20230201Open filing evidence
2021-04-01 – 2021-06-301105911000 USD20220803Open filing evidence
2020-10-01 – 2021-06-303039254000 USD20220803Open filing evidence

Other Healthcare Solutions · International Healthcare Solutions · Operating Segments

Subsegments · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:SubsegmentsAxis=abc:OtherHealthcareSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=abc:InternationalHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-311203999000 USD20230502Open filing evidence
2022-10-01 – 2023-03-312354586000 USD20230502Open filing evidence
2022-01-01 – 2022-03-311168219000 USD20230502Open filing evidence
2021-10-01 – 2022-03-312261330000 USD20230502Open filing evidence

Alliance Healthcare · Operating Segments · International Healthcare Solutions

Subsegments · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:SubsegmentsAxis=cor:AllianceHealthcareMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2023-10-01 – 2023-12-315725564000 USD20240131Open filing evidence
2022-10-01 – 2022-12-315460691000 USD20240131Open filing evidence

Animal Health · Operating Segments · US Healthcare Solutions

Subsegments · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:SubsegmentsAxis=cor:AnimalHealthMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cor:USHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2022-10-01 – 2023-09-305042549000 USD20231121Open filing evidence
2021-10-01 – 2022-09-304815758000 USD20231121Open filing evidence
2020-10-01 – 2021-09-304684417000 USD20231121Open filing evidence

Animal Health · US Healthcare Solutions · Operating Segments

Subsegments · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:SubsegmentsAxis=cor:AnimalHealthMember;us-gaap:StatementBusinessSegmentsAxis=cor:USHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-10-01 – 2023-12-311285637000 USD20240131Open filing evidence
2022-10-01 – 2022-12-311159966000 USD20240131Open filing evidence

Human Health · Operating Segments · US Healthcare Solutions

Subsegments · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:SubsegmentsAxis=cor:HumanHealthMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cor:USHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-3159984359000 USD20240501Open filing evidence
2023-10-01 – 2024-03-31123882524000 USD20240501Open filing evidence
2023-01-01 – 2023-03-3155453964000 USD20240501Open filing evidence
2022-10-01 – 2023-03-31110530577000 USD20240501Open filing evidence

Other Healthcare Solutions · Operating Segments · International Healthcare Solutions

Subsegments · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:SubsegmentsAxis=cor:OtherHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember
PeriodValueUnitFiledEvidence
2023-10-01 – 2023-12-311344663000 USD20240131Open filing evidence
2022-10-01 – 2022-12-311150587000 USD20240131Open filing evidence

Other Healthcare Solutions · International Healthcare Solutions · Operating Segments

Subsegments · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:SubsegmentsAxis=cor:OtherHealthcareSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=cor:InternationalHealthcareSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-10-01 – 2023-09-305069401000 USD20231121Open filing evidence
2021-10-01 – 2022-09-304601271000 USD20231121Open filing evidence
2020-10-01 – 2021-09-304156264000 USD20231121Open filing evidence